Citazione APA

Liu, M., Zhang, L., Huang, Q., Li, N., Zheng, B., & Cai, H. (2019). Cost-Effectiveness Analysis Of Ceritinib And Alectinib Versus Crizotinib In The Treatment Of Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer. Cancer Manag Res.

Stile di citazione Chicago

Liu, Maobai, Longfeng Zhang, Qishu Huang, Na Li, Bin Zheng, e Hongfu Cai. "Cost-Effectiveness Analysis Of Ceritinib And Alectinib Versus Crizotinib In The Treatment Of Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer." Cancer Manag Res 2019.

Citazione MLA

Liu, Maobai, et al. "Cost-Effectiveness Analysis Of Ceritinib And Alectinib Versus Crizotinib In The Treatment Of Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer." Cancer Manag Res 2019.

Attenzione: Queste citazioni potrebbero non essere precise al 100%.